← Open Payments lookup

SARAH TAZA: Open Payments

NPI 1285191841 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$798 in 37 payments from 11 companies in 2025. Trend: 2023 $1,105 · 2024 $745 · 2025 $798

Food & beverage: $798
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.7$182
AstraZeneca Pharmaceuticals LP7$132
Takeda Pharmaceuticals U.S.A., Inc.5$122
Grifols USA, LLC3$63
ABBVIE INC.2$56
GlaxoSmithKline, LLC.3$52
GENZYME CORPORATION2$51
Viatris Specialty LLC3$48
Boehringer Ingelheim Pharmaceuticals, Inc.2$43
Actelion Pharmaceuticals US, Inc.2$29

Products named: DUPIXENT, GLASSIA, Prolastin-C Liquid, TRELEGY ELLIPTA, AIRSUPRA, YUPELRI, FASENRA, TEZSPIRE.

Industry payments across IN — which companies pay providers there.